Login to Your Account



Synergy Constipation Drug Begins Phase III

By Catherine Shaffer
Staff Writer

Wednesday, November 13, 2013
Synergy Pharmaceuticals Inc. launched the first of two Phase III trials of its investigational drug for chronic idiopathic constipation, plecanatide. The 12-week trial will enroll about 1,350 patients with an endpoint of overall response.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription